Liste d'obligations internationales ( Toutes )
| Société émettrice | Code ISIN | Devise | Coupon | Montant minimal | Maturité | Prix sur le marché | |
| AmgenX | US031162AZ32 | USD | 5.7% | 2 000 USD | 01/02/2019 | Echue | |
| AmgenX | USU03160AX38 | USD | 2.77% | 2 000 USD | 31/08/2053 | 100 | |
| AmgenX | US031162BF68 | USD | 2.3% | 2 000 USD | 15/06/2016 | Echue | |
| AmgenX | US031162AV28 | USD | 5.85% | 2 000 USD | 01/06/2017 | Echue | |
| AmgenX | US031162AJ99 | USD | 4.85% | 1 000 USD | 18/11/2014 | Echue | |
| AmgenX | USU03160AQ86 | USD | 4.663% | 2 000 USD | 15/06/2051 | 94.744 | |
| AmgenX | US031162CD02 | USD | 4.563% | 2 000 USD | 15/06/2048 | 100 | |
| AmgenX | US031162BW91 | USD | 2.125% | 2 000 USD | 01/05/2020 | Echue | |
| AmgenX | US031162CK45 | USD | 1.9% | 2 000 USD | 10/05/2019 | Echue | |
| AmgenX | US031162CZ14 | USD | 2% | 2 000 USD | 15/01/2032 | 84.6217 | |
| AmgenX | US031162AA80 | USD | 8.125% | 1 000 USD | 01/04/2097 | 100 | |
| AmgenX | US031162CM01 | USD | 2.2% | 2 000 USD | 11/05/2020 | Echue | |
| AmgenX | US031162CY49 | USD | 2.77% | 2 000 USD | 01/09/2053 | 100 | |
| AmgenX | US031162CJ71 | USD | 2.6% | 2 000 USD | 19/08/2026 | 98.167 | |
| AmgenX | US031162DB37 | USD | 1.65% | 2 000 USD | 15/08/2028 | 100 | |
| AmgenX | US031162DA53 | USD | 2.8% | 2 000 USD | 15/08/2041 | 67.797 | |
| AmgenX | US031162CG33 | USD | 1.85% | 2 000 USD | 19/08/2021 | Echue | |
| AmgenX | US031162CH16 | USD | 2.25% | 2 000 USD | 19/08/2023 | Echue | |
| AmgenX | XS0710090928 | EUR | 4.375% | 100 000 EUR | 05/12/2018 | Echue | |
| AmgenX | US031162CF59 | USD | 4.663% | 2 000 USD | 15/06/2051 | 100 | |
| AmgenX | US031162BJ80 | USD | 1.875% | 2 000 USD | 15/11/2014 | Echue | |
| AmgenX | US031162BQ24 | USD | 2.125% | 2 000 USD | 15/05/2017 | Echue | |
| AmgenX | US031162BS89 | USD | 0% | 2 000 USD | 22/05/2017 | Echue | |
| AmgenX | US031162AX83 | USD | 6.15% | 2 000 USD | 01/06/2018 | Echue | |
| AmgenX | US031162BB54 | USD | 4.5% | 2 000 USD | 15/03/2020 | Echue | |
| AmgenX | XS0829324457 | GBP | 4% | 12/09/2029 | 98 | ||
| AmgenX | US031162CW82 | USD | 2.3% | 24/02/2031 | 90.561 | ||
| AmgenX | US031162CQ15 | USD | 3.2% | 01/11/2027 | 98.365 | ||
| AmgenX | US031162DN74 | USD | 5.507% | 2 000 USD | 02/03/2026 | 99.95 | |
| AmgenX | US031162DQ06 | USD | 5.25% | 2 000 USD | 02/03/2030 | 102.735 | |
| AmgenX | US031162DM91 | USD | 5.25% | 2 000 USD | 02/03/2025 | Echue | |
| AmgenX | US031162DS61 | USD | 5.6% | 2 000 USD | 02/03/2043 | 99.8031 | |
| AmgenX | US031162DU18 | USD | 5.75% | 2 000 USD | 02/03/2063 | 97.049 | |
Amgen is a leading biotechnology company focused on developing and delivering innovative therapies for serious illnesses in areas such as oncology, cardiovascular disease, and inflammation.
Amgen est une société biopharmaceutique multinationale qui se concentre sur la découverte, le développement, la fabrication et la commercialisation de produits biologiques principalement utilisés pour le traitement du cancer, des maladies rhumatismales, des maladies cardiovasculaires et des maladies osseuses.
Amgen è una società biotecnologica multinazionale leader nella scoperta, nello sviluppo, nella produzione e nella commercializzazione di farmaci biologici innovativi per il trattamento di gravi malattie.